W10 MS Flashcards

1
Q

what are Demyelinating disorders?

A
  • alterations in CNS structures
  • result of damage to the myelin nerve sheath and affect neural transmission
  • can occur in either the central (e.g. MS) or peripheral (e.g., Guillani-Barre Syndrome nervous system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is Multiple Sclerosis?

A

-Progressive, chronic, inflammatory, demyelinating, autoimmune disorder of the CNS
-degeneration of CNS myelin
-Scarring (Sclerosis or plaque formation)
-Loss of axon
-onset is 20-40 yrs of age
Etiology is unknown but affects mainly women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the risk factors to multiple sclerosis?

A

Smoking, vitamin D deficiency, and Epstein-Barr virus infection
“Clinically isolated syndrome”: single episode neurologic dysfunction (lasting 24 hrs), precursor to MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the patho of MS?

A

-Diffuse and progressive CNS inflammatory autoimmune disease that affects white and gray matter
-Autoreactive T & B cells and macrophages breach blood-brain barrier and spinal cord accompanied by upregulation of adhesion molecules and inflammation
-Recognize myelin autoantigens which produce antibodies and cause inflammation demyelination
-Loss of myelin sheaths, relative preservation of axons, and glial (astrocytic) scar formation
Diffuse injury and CNS–> MS lesions occur anywhere in white or grey matter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the consequences of MS pathophysiology?

A
  • loss of myelin–> which disrupts the nerve conduction and cause symptoms
  • also neurons die and brain atrophies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is clinically isolated syndrome?

A
  • an acute neurologic episode, is the first manifestation of the disease
  • Symptoms: Paresthesias of the face, trunk, or limbs; weakness; impaired gait; visual, hearing & speech abnormalities; or urinary incontinence, indicating diffuse CNS involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is optic neuritis

A

one eye with progressive blurring vision and pain with eye movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is spinal cord syndrome?

A

both sensory and motor tracts starting on one side and progressing to the other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is brainstorm syndrome?

A

facial sensory loss or weakness, vertigo, or double vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is cerebellar syndrome?

A

lack of coordination, tremor, gait instability, and ataxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is cognitive deficits?

A

-memory and attention as well as later dementia and psychiatric disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

symptoms subtypes of MS

-relapsing/remitting

A

Most common and is characterized by relapses or exacerbations (flares) of previous symptoms or worsening of neurologic symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

symptom subtypes of MS

primary progressive MS

A

-least common and is characterized characterized by a gradual progression of the disease without periods of remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

symptom subtypes of MS (secondary progressive MS)

A

Characterized by an initial period of relapsing/remitting MS followed by a gradual worsening of the symptoms between relapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

symptom subtypes of MS (progressive relapsing MS (PRMS)

A

Characterized by steadily worsening symptoms from the onset with clear acute relapses but often with more severe symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

evaluation and treatment of MS

A
  • no single test available to diagnose or rule out MS
  • treatment: prevent exacerbations and control symptoms
  • corticosteroids
  • immunotherapy
  • immune system modulators
  • continuous monitoring
  • vitamin D
  • stem cells
17
Q

non pharamoctherpay treatment

A
  • Regular exercise program
  • Smoking cessation
  • Avoidance of overwork, extreme fatigue, and heat exposure
18
Q

goal of pharmacotherapy

A
  • is to slow the progression of MS
    -Immunomodulators are the main strategy to modify the abnormal immune response and prevent exacerbations
    Initiated after diagnosis of MS is confirmed
    -Two basic types used in MS
    -Those that simulate or boost the immune response
    -Those that suppress some aspect of immune function
19
Q

Interferon Beta-1b: betaseron

A
  • Indication: Ambulatory patients with relapsing or remitting multiple sclerosis
  • Mechanisms of action: drug that’s not clearly understood. Believed to act by suppressing the activity of T-cells and reducing the inflammatory actions of cytokines.
  • Desired effects: Decreased symptoms of multiple sclerosis
20
Q

Interferon Beta-1b: Betaseron-adverse effects

A

Adverse effects: transient flu-like symptoms, leukopenia, headache, insomnia, asthenia, increased liver enzymes, rash, peripheral edema, and malaise

21
Q

non-pharamolgocial interventions for MS

A
  • protect pt from injury
  • promote regular bladder and bladder elimination
  • instruct the pt in safety measure r/t sensory and motor loss
  • encourage independence